Detection of extrathoracic metastases by positron emission tomography in lung cancer

Annals of Thoracic Surgery

Volumn 66, Issue 3, 1998, Pages 886-892

  Weder, Walter ^a   Schmid, Ralph A ^a   Bruchhaus, Helke ^a   Hillinger, Sven ^a   Von Schulthess, Gustav K ^a   Steinert, Hans C ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WHOLE BODY SCINTISCANNING;

EID: 0032168590     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)00675-4     Document Type: Article

References (18)

1. 1. Warburg O. The metabolism of tumors. New York: Smith, 1931;167-81.
2. 2. Nolop KB, Rhodes CG, Brudin LH, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987;60: 2682-9.
3. 3. Lowe VJ, DeLong DM, Hoffman JM, Coleman RE. Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy. J Nucl Med 1995;36:883-7.
4. 4. Steinert HC, Hauser M, Allemann F, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997;202:441-6.
5. 18F]-fluoro-2-deoxy-D-glucose using amino-polyether supported nucleophilic substitution. J Nucl Med 1986;27:235-8.
6. 6. Engel H, Steinert H, Buck A, Berthold T, Huch Böni RA, von Schulthess GK. Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996;37: 441-6.
7. 7. Tisi GM, Friedman PJ, Peters EM, et al. American Thoracic Society: clinical staging of primary lung cancer. Am Rev Respir Dis 1983;127:659-64.
8. 8. Friedman PJ. Lung cancer: update on staging classifications. Am J Radiol 1988;150:261-4.
9. 9. Valk PE, Pounds TR, Hopkins DM, et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg 1995;60:1573-82.
10. 10. Chin R, Ward R, Keyes JW, et al. Mediastinal staging of non-small cell lung cancer with positron emission tomography. Am J Respir Crit Care Med 1995;152:2090-6.
11. 11. Rigo P, Paulus P, Kaschten BJ, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996;23:1641-74.
12. 12. Jacobson AF, Cronin EB, Stomper PC, Kaplan WD. Bone scans with one or two new abnormalities in cancer patients with no known metastases: frequency and serial scintigraphic behavior of benign and malignant lesions. Radiology 1990;175:229-32.
13. 13. Silvestri GA, Littenberg B, Colice GL. The clinical evaluation for detecting metastatic lung cancer. A meta-analysis. Am J Respir Crit Care Med 1995;152:225-30.
14. 14. Dehdashti F, Siegel BA, Griffeth LK, et al. Benign versus malignant intraosseus lesions: discrimination by means of PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1996; 200:243-7.
15. 15. Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 1996;37:943-8.
16. 16. Patz EF, Lowe VJ, Hoffmann JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993;188:487-90.
17. 17. Erasmus JJ, Patz EF, McAdams HP, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. Am J Radiol 1997;168:1357-62.
18. 18. Block MI, Patterson GA, Sundaresan RS, et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 1997;64:770-7.